Cargando…
Research highlights of clinical oncology early 2022
Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therap...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255546/ https://www.ncbi.nlm.nih.gov/pubmed/37520335 http://dx.doi.org/10.1007/s44178-022-00006-9 |
_version_ | 1784740943652454400 |
---|---|
author | Wu, Kaichun |
author_facet | Wu, Kaichun |
author_sort | Wu, Kaichun |
collection | PubMed |
description | Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody–drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed. |
format | Online Article Text |
id | pubmed-9255546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-92555462022-07-06 Research highlights of clinical oncology early 2022 Wu, Kaichun Holist Integ Oncol Review Advance in clinical oncology is highly relied on development of cancer research and clinical trials. There has been ample evidence regarding the new therapeutic drugs, agents or techniques for the treatment of cancer. We did a broad literature search to catch the latest progress in the cancer therapy. Here is a brief review of the newly released results of clinical trials including surgical modalities, immune checkpoint blockade, chimeric antigen receptor T-cell (CAR T) therapy, antibody–drug conjugates and tumor vaccines, etc. Biomarkers or patient assessment of cancer therapy were also discussed. Springer Nature Singapore 2022-07-05 2022 /pmc/articles/PMC9255546/ /pubmed/37520335 http://dx.doi.org/10.1007/s44178-022-00006-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Wu, Kaichun Research highlights of clinical oncology early 2022 |
title | Research highlights of clinical oncology early 2022 |
title_full | Research highlights of clinical oncology early 2022 |
title_fullStr | Research highlights of clinical oncology early 2022 |
title_full_unstemmed | Research highlights of clinical oncology early 2022 |
title_short | Research highlights of clinical oncology early 2022 |
title_sort | research highlights of clinical oncology early 2022 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255546/ https://www.ncbi.nlm.nih.gov/pubmed/37520335 http://dx.doi.org/10.1007/s44178-022-00006-9 |
work_keys_str_mv | AT wukaichun researchhighlightsofclinicaloncologyearly2022 |